3I06
Crystal structure of cruzain covalently bound to a purine nitrile
3I06 の概要
| エントリーDOI | 10.2210/pdb3i06/pdb |
| 分子名称 | Cruzipain, 6-[(3,5-difluorophenyl)amino]-9-ethyl-9H-purine-2-carbonitrile (3 entities in total) |
| 機能のキーワード | autocatalytic cleavage, glycoprotein, protease, thiol protease, zymogen, hydrolase |
| 由来する生物種 | Trypanosoma cruzi |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 23015.40 |
| 構造登録者 | |
| 主引用文献 | Mott, B.T.,Ferreira, R.S.,Simeonov, A.,Jadhav, A.,Ang, K.K.,Leister, W.,Shen, M.,Silveira, J.T.,Doyle, P.S.,Arkin, M.R.,McKerrow, J.H.,Inglese, J.,Austin, C.P.,Thomas, C.J.,Shoichet, B.K.,Maloney, D.J. Identification and optimization of inhibitors of trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB. J.Med.Chem., 53:52-60, 2010 Cited by PubMed Abstract: Trypanosoma cruzi and Trypanosoma brucei are parasites that cause Chagas' disease and African sleeping sickness, respectively. Both parasites rely on essential cysteine proteases for survival: cruzain for T. cruzi and TbCatB/rhodesain for T. brucei. A recent quantitative high-throughput screen of cruzain identified triazine nitriles, which are known inhibitors of other cysteine proteases, as reversible inhibitors of the enzyme. Structural modifications detailed herein, including core scaffold modification from triazine to purine, improved the in vitro potency against both cruzain and rhodesain by 350-fold, while also gaining activity against T. brucei parasites. Selected compounds were screened against a panel of human cysteine and serine proteases to determine selectivity, and a cocrystal was obtained of our most potent analogue bound to cruzain. PubMed: 19908842DOI: 10.1021/jm901069a 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.1 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






